Mitigation of Sepsis-Induced Acute Lung Injury by BMSC-Derived Exosomal miR-125b-5p Through STAT3-Mediated Suppression of Macrophage Pyroptosis
Yiming Tao,Xinxin Xu,Bin Yang,Hui Zhao,Yongsheng Li
DOI: https://doi.org/10.2147/ijn.s441133
IF: 7.033
2023-11-30
International Journal of Nanomedicine
Abstract:Yiming Tao, 1, 2 Xinxin Xu, 1, 2 Bin Yang, 1, 2 Hui Zhao, 1, 2 Yongsheng Li 1, 2 1 Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 2 Emergency Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China Correspondence: Yongsheng Li, Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, People's Republic of China, Email Introduction: Sepsis is a syndrome characterized by high morbidity and mortality rates. One of its most severe complications is acute lung injury, which exhibits a multitude of clinical and biological features, including macrophage pyroptosis. This study investigates the regulatory effects of exosomes derived from Bone Marrow-Derived Mesenchymal Stem Cells (BMSCs) on sepsis-associated acute lung injury (ALI) and explores the potential mechanisms mediated by exosomal miRNAs. Methods: Exosomes were isolated from primary BMSCs of adult C57BL/6J mice using differential centrifugation. Their uptake and distribution in both in vitro and in vivo contexts were validated. Key sepsis-associated hub gene signal transducer and activator of transcription 3 (STAT3) and its upstream non-coding miR-125b-5p were elucidated through a combination of bioinformatics, machine learning, and miRNA sequencing. Subsequently, the therapeutic potential of BMSC-derived exosomes in alleviating sepsis-induced acute lung injury was substantiated. Moreover, the functionalities of miR-125b-5p and STAT3 were corroborated through miR-125b-5p inhibitor and STAT3 agonist interventions, employing gain and loss-of-function strategies both in vitro and in vivo. Finally, a dual-luciferase reporter assay reaffirmed the interaction between miR-125b-5p and STAT3. Results: We isolated exosomes from primary BMSCs and confirmed their accumulation in the mouse lung as well as their uptake by macrophages in vitro. This study identified the pivotal sepsis-associated hub gene STAT3 and demonstrated that exosomes derived from BMSCs can target STAT3, thereby inhibiting macrophage pyroptosis. MiR-125b-5p inhibition experiments showed that exosomes mitigate macrophage pyroptosis and lung injury by delivering miR-125b-5p. STAT3 overexpression experiments validated that miR-125b-5p reduces macrophage pyroptosis and lung injury by suppressing STAT3. Furthermore, a dual-luciferase reporter assay confirmed the binding interaction between miR-125b-5p and STAT3. Conclusion: Exosomes derived from BMSCs, serving as carriers for delivering miR-125b-5p, can downregulate STAT3, thereby inhibiting macrophage pyroptosis and alleviating sepsis-associated ALI. These significant findings provide valuable insights into the potential development of ALI therapies centred around exosomes derived from BMSC. Keywords: mesenchymal stem cells, exosomes, acute lung injury, machine learning, miR-125b-5p, STAT3 Sepsis, a condition characterized by inflammation resulting from infections, is responsible for approximately 20% of global deaths each year and exhibits complex pathological and physiological features. 1 Among its complications, acute lung injury (ALI) emerges as an early and severe complication of sepsis, with sepsis serving as a primary etiological factor for ALI. 2 ALI is a life-threatening pathological condition characterized by uncontrolled inflammation leading to damage of the pulmonary endothelial and epithelial cell barriers. The development of sepsis-induced ALI involves complex interactions among various factors, such as pathogens, host immune responses, multi-organ dysfunction, and medical interventions. 3,4 Consequently, patients afflicted by ALI exhibit diverse physiological and biochemical profiles, making it challenging to implement precise therapeutic strategies. 5 Central to the pathogenesis of ALI are macrophages. 6 Operating within distinct microenvironments during various pathological stages, 7 macrophages contribute to ALI by releasing an array of molecules, undergoing polarization, and experiencing different forms of cell death, 8 all while orchestrating inflammatory cascades. 9 Of particular note, macrophage pyroptosis emerges as a critical factor in ALI. 10 Pyroptosis, a caspase-1-dependent subtype of pro-inflammatory cell death, has a dual role: defending against microbial pathogens and triggering inflammation. 11 However, this infla -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology